Management of patients with advanced epithelial ovarian cancer: a European survey-Reference-Cited by-同舟云学术

Management of patients with advanced epithelial ovarian cancer: a European survey

Published:2023-02-03 Issue:2 Volume:308 Page:535-549
ISSN:1432-0711
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Jochum Floriane^ORCID,Angeles Martina Aida,Balaya Vincent,Drouin Leonor,Nikolova Tanja,Mathevet Patrice,Lécuru Fabrice,Azais Henri,Betrian Sarah,Bolze Pierre-Adrien,Dabi Yohann,Kerbage Yohan,Sanson Claire,Zaccarini François,Guyon Fréderic,Akladios Cherif,Hsu Arthur,Bendifallah Sofiane,Deluche Elise,Guani Benedetta

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00404-023-06948-3.pdf

Reference44 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

2. Pavlidis N, Rassy E, Vermorken JB, Assi T, Kattan J, Boussios S, Smith-Gagen J (2021) The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment Eras: 27 years data from the SEER registry. Cancer Epidemiol 75:102045

3. Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I, Morice P, Pignata S, Ray-Coquard I, Vergote I et al (2019) ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. Ann Oncol 30:672–705. https://doi.org/10.1093/annonc/mdz062

4. Chi DS, Eisenhauer EL, Zivanovic O, Sonoda Y, Abu-Rustum NR, Levine DA, Guile MW, Bristow RE, Aghajanian C, Barakat RR (2009) Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol 114:26–31. https://doi.org/10.1016/j.ygyno.2009.03.018

5. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248–1259. https://doi.org/10.1200/JCO.2002.20.5.1248

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population-based target trial emulation;American Journal of Obstetrics and Gynecology;2024-08